1. Home
  2. SLRX vs CISS Comparison

SLRX vs CISS Comparison

Compare SLRX & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • CISS
  • Stock Information
  • Founded
  • SLRX N/A
  • CISS 2022
  • Country
  • SLRX United States
  • CISS Greece
  • Employees
  • SLRX N/A
  • CISS N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • CISS Marine Transportation
  • Sector
  • SLRX Health Care
  • CISS Consumer Discretionary
  • Exchange
  • SLRX Nasdaq
  • CISS Nasdaq
  • Market Cap
  • SLRX 2.9M
  • CISS 2.5M
  • IPO Year
  • SLRX N/A
  • CISS N/A
  • Fundamental
  • Price
  • SLRX $5.29
  • CISS $2.27
  • Analyst Decision
  • SLRX
  • CISS
  • Analyst Count
  • SLRX 0
  • CISS 0
  • Target Price
  • SLRX N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • SLRX 129.8K
  • CISS 303.8K
  • Earning Date
  • SLRX 11-13-2025
  • CISS 09-02-2025
  • Dividend Yield
  • SLRX N/A
  • CISS N/A
  • EPS Growth
  • SLRX N/A
  • CISS N/A
  • EPS
  • SLRX N/A
  • CISS 5.74
  • Revenue
  • SLRX N/A
  • CISS $38,084,901.00
  • Revenue This Year
  • SLRX N/A
  • CISS N/A
  • Revenue Next Year
  • SLRX N/A
  • CISS N/A
  • P/E Ratio
  • SLRX N/A
  • CISS $0.40
  • Revenue Growth
  • SLRX N/A
  • CISS N/A
  • 52 Week Low
  • SLRX $4.50
  • CISS $2.03
  • 52 Week High
  • SLRX $108.00
  • CISS $18.75
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 39.91
  • CISS 30.89
  • Support Level
  • SLRX $4.50
  • CISS $2.03
  • Resistance Level
  • SLRX $5.65
  • CISS $3.80
  • Average True Range (ATR)
  • SLRX 0.40
  • CISS 0.15
  • MACD
  • SLRX 0.18
  • CISS -0.06
  • Stochastic Oscillator
  • SLRX 44.38
  • CISS 21.33

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: